Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 6 results

Author Title Type [ Year

]

Filters: Author is Sitar, Sandra [Clear All Filters]

2017

Ledgerwood, Julie E, Adam D DeZure, Daphne A Stanley, Emily E Coates, Laura Novik, Mary E Enama, Nina M Berkowitz, et al.. 2017. “Chimpanzee Adenovirus Vector Ebola Vaccine.”. N Engl J Med 376 (10). N Engl J Med: 928-938. doi:10.1056/NEJMoa1410863.

2015

Crank, Michelle C, Ingelise J Gordon, Galina V Yamshchikov, Sandra Sitar, Zonghui Hu, Mary E Enama, LaSonji A Holman, et al.. 2015. “Phase 1 Study Of Pandemic H1 Dna Vaccine In Healthy Adults.”. Plos One 10 (4). Plos One: e0123969. doi:10.1371/journal.pone.0123969.

Sarwar, Uzma N, Pamela Costner, Mary E Enama, Nina Berkowitz, Zonghui Hu, Cynthia S Hendel, Sandra Sitar, et al.. 2015. “Safety And Immunogenicity Of Dna Vaccines Encoding Ebolavirus And Marburgvirus Wild-Type Glycoproteins In A Phase I Clinical Trial.”. J Infect Dis 211 (4). J Infect Dis: 549-57. doi:10.1093/infdis/jiu511.

Kibuuka, Hannah, Nina M Berkowitz, Monica Millard, Mary E Enama, Allan Tindikahwa, Arthur B Sekiziyivu, Pamela Costner, et al.. 2015. “Safety And Immunogenicity Of Ebola Virus And Marburg Virus Glycoprotein Dna Vaccines Assessed Separately And Concomitantly In Healthy Ugandan Adults: A Phase 1B, Randomised, Double-Blind, Placebo-Controlled Clinical Trial.”. Lancet 385 (9977). Lancet: 1545-54. doi:10.1016/S0140-6736(14)62385-0.

2014

Chang, Lee-Jah, Kimberly A Dowd, Floreliz H Mendoza, Jamie G Saunders, Sandra Sitar, Sarah H Plummer, Galina Yamshchikov, et al.. 2014. “Safety And Tolerability Of Chikungunya Virus-Like Particle Vaccine In Healthy Adults: A Phase 1 Dose-Escalation Trial.”. Lancet 384 (9959). Lancet: 2046-52. doi:10.1016/S0140-6736(14)61185-5.

2013

Ledgerwood, Julie E, Kathryn Zephir, Zonghui Hu, Chih-Jen Wei, Leejah Chang, Mary E Enama, Cynthia S Hendel, et al.. 2013. “Prime-Boost Interval Matters: A Randomized Phase 1 Study To Identify The Minimum Interval Necessary To Observe The H5 Dna Influenza Vaccine Priming Effect.”. J Infect Dis 208 (3). J Infect Dis: 418-22. doi:10.1093/infdis/jit180.